Cyclerion Therapeutics Inc. (CYCN)
NASDAQ · Healthcare
Cyclerion Therapeutics Inc. Revenue 2019–2025
Cyclerion Therapeutics Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cyclerion Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Cyclerion Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 1.0 M, a 440.72% increase year-over-year.
- Cyclerion Therapeutics Inc. annual revenue for 2025 was 2.1 M, a 3.70% increase from 2024.
- Cyclerion Therapeutics Inc. annual revenue for 2024 was 2.0 M.
- Cyclerion Therapeutics Inc. annual revenue for 2023 was 0, a 100.00% decrease from 2022.
- Cyclerion Therapeutics Inc. annual revenue for 2022 was 297000.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cyclerion Therapeutics Inc. Earnings — FAQ
Cyclerion Therapeutics Inc. (CYCN) earnings over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CYCN's earnings history?
The chart and table above show Cyclerion Therapeutics Inc.'s earnings by year and by quarter, including the growth rate.